AGIO:NASDAQ
Agios Pharmaceuticals Inc
၂၉.၄၂ US$
arrow_downward
-၁.၅၇%(-၀.၄၇) 1D
နို ၁၈, GMT-၅ ၁၃:၀၆:၅၈ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
၂၉.၅၇ US$
High
၃၀.၄၈ US$
Low
၂၉.၂၂ US$
Mkt. cap
၁၇၅.၉၆ ဋေ
Avg. vol.
၁.၂၁ သန်း
Volume
၁.၀၆ သိန်း
52-wk high
၄၄.၀၇ US$
52-wk low
၂၂.၂၄ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
Open
၂၉.၅၇ US$
High
၃၀.၄၈ US$
Low
၂၉.၂၂ US$
Mkt. cap
၁၇၅.၉၆ ဋေ
Avg. vol.
၁.၂၁ သန်း
Volume
၁.၀၆ သိန်း
52-wk high
၄၄.၀၇ US$
52-wk low
၂၂.၂၄ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
News stories
From web sources and news partners
24/7 Wall St.
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 Slides 0.6% at Midday as the Dow Drops Over 1%
TradingView
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500, Nasdaq find footing as Nvidia treads water
ChartMill
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500 Gap-Down Movers for Nov. 18 Session
JournalArta
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 Futures Rise After Nvidia Raises Sales Forecast
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc